These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1009703)

  • 41. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
    Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract]   [Full Text] [Related]  

  • 43. Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study.
    Sutow WW; Sullivan MP; Fernbach DJ; Cangir A; George SL
    Cancer; 1975 Nov; 36(5):1598-602. PubMed ID: 1059501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
    Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
    Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of nandrolone phenpropionate on myelopoiesis.
    Kahn SB; Conroy JF; Brodsky I
    J Med; 1974; 5(6):303-9. PubMed ID: 4528544
    [No Abstract]   [Full Text] [Related]  

  • 46. Granulocyte alkaline phosphatase activity: a measure of the emergence time of mature marrow neutrophils?
    Kelemen E
    Acta Haematol; 1973; 50(1):19-24. PubMed ID: 4200799
    [No Abstract]   [Full Text] [Related]  

  • 47. Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
    Cole MP; Todd ID; Wilkinson PM
    Br J Cancer; 1973 May; 27(5):396-9. PubMed ID: 4576562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment-induced complications and frequent errors in cytostatic therapy].
    Senn HJ
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1216-22. PubMed ID: 675216
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatic-vein thrombosis after chemotherapy for histiocytoma.
    Lehrner LM; Enck RE
    Ann Intern Med; 1978 Apr; 88(4):575-6. PubMed ID: 205156
    [No Abstract]   [Full Text] [Related]  

  • 50. [Complications in oncologic therapy].
    Nagel GA
    Dtsch Med Wochenschr; 1974 May; 99(18):960-1. PubMed ID: 4835543
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapy of histiocytosis X with vincristine, vinblastine, and cyclophosphamide. The Southwest Cancer Chemotherapy Study Group.
    Starling KA; Donaldson MH; Haggard ME; Vietti TJ; Sutow WW
    Am J Dis Child; 1972 Feb; 123(2):105-10. PubMed ID: 5025854
    [No Abstract]   [Full Text] [Related]  

  • 52. Images in clinical medicine. Chemotherapy-induced hyperpigmentation of the tongue.
    Blaya M; Saba N
    N Engl J Med; 2011 Sep; 365(10):e20. PubMed ID: 21899446
    [No Abstract]   [Full Text] [Related]  

  • 53. The etiocholanolone test for prediction of the leukopenic effect of cytoxic drugs.
    Karjalainen J; Wasastjerna C
    Scand J Haematol; 1973; 11(5):337-41. PubMed ID: 4778496
    [No Abstract]   [Full Text] [Related]  

  • 54. [The oncologic emergency: leukocytopenia during cytostatic therapy].
    Bruntsch U
    MMW Munch Med Wochenschr; 1979 May; 121(18):623-4. PubMed ID: 108585
    [No Abstract]   [Full Text] [Related]  

  • 55. THE USE OF TRENIMON AND DECA-DURABOLIN IN RECURRENT GYNAECOLOGICAL CARCINOMA.
    RAURAMO L; GROENROOS M
    Ann Chir Gynaecol Fenn; 1964; 53():115-9. PubMed ID: 14120480
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of effect of pretreatment blood-transfusions on drug-induced myelodepression.
    Helson L; Polesir E; Silverman M
    Lancet; 1976 Nov; 2(7993):1033. PubMed ID: 62261
    [No Abstract]   [Full Text] [Related]  

  • 57. [Toxic lesions caused by cytostatic drugs].
    Gropp C; Havemann K
    Internist (Berl); 1980 Dec; 21(12):739-45. PubMed ID: 7009476
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of cytostatic therapy on cellular immunity in vitro.
    Winnewisser M; Theml H; Begemann H
    Recent Results Cancer Res; 1975; (52):107-13. PubMed ID: 1087741
    [No Abstract]   [Full Text] [Related]  

  • 59. Augmentation of vincristine-induced thrombocytosis by norethisterone.
    Cantwell BM; Begent RH; Rubens RD
    Eur J Cancer (1965); 1979 Aug; 15(8):1065-9. PubMed ID: 510343
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experience with 19-nor-androstenolone undecylate, a steroid with anabolic and psychosomatic activity].
    Savino F; Trasciatti S
    Farmaco Prat; 1979 Oct; 34(10):456-61. PubMed ID: 510524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.